Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review

Date: January 16, 2014
Pages: 37
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: A14D1326C89EN
Leaflet:

Download PDF Leaflet

Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review
Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Agenix Limited (Agenix) is a biopharmaceutical company. It develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of Hepatitis-B and other diseases. The company divides its business into three segments, namely, ThromboView, AGX-1009 and DiagnostIQ. ThromboView is a patented novel radio-labeled monoclonal antibody imaging agent being developed to diagnose patients suffering from acute pulmonary embolism. AGX-1009 is a reverse transcriptase inhibitor (NtRTI) prodrug of tenofovir.

Agenix Limited Key Recent Developments

May 21, 2013: Appointment of Non- Executive Director

Key benefits of buying this profile include:
  • You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
  • Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
  • Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
  • Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
  • Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Agenix Limited - Key Facts
Agenix Limited - Key Employees
Agenix Limited - Key Employee Biographies
Agenix Limited - Major Products and Services
Agenix Limited - Pharmaceutical Pipeline Products Data
Agenix Limited, Pipeline Products by Therapy Area
Agenix Limited, Pipeline Products by Development Phase
Agenix Limited - History
Agenix Limited - Company Statement
Agenix Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Agenix Limited - Business Description
Agenix Limited - SWOT Analysis
SWOT Analysis - Overview
Agenix Limited - Strengths
Strength - Focused R&D Activities
Strength - Strong Intellectual Property
Strength - Established Operations in China
Agenix Limited - Weaknesses
Weakness - Negative Operating Margin
Weakness - Legal Claims
Agenix Limited - Opportunities
Opportunity - Emerging Markets
Opportunity - Growing Point-of-Care Testing Market
Opportunity - Changing Demographics
Agenix Limited - Threats
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
Threat - Rapid Technological Change
Agenix Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Agenix Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Agenix Limited, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Agenix Limited, Recent Developments
May 21, 2013: Appointment of Non- Executive Director

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Agenix Limited, Key Facts
Agenix Limited, Key Employees
Agenix Limited, Key Employee Biographies
Agenix Limited, Major Products and Services
Agenix Limited, Number of Pipeline Products by Therapy Area
Agenix Limited, Number of Pipeline Products by Development Stage
Agenix Limited, Pipeline Products By Therapy Area and Development Phase
Agenix Limited, History
Agenix Limited, Subsidiaries
Agenix Limited, Key Competitors
Agenix Limited, Ratios based on current share price
Agenix Limited, Annual Ratios
Agenix Limited, Interim Ratios
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Agenix Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Agenix Limited, Pipeline Products by Therapy Area
Agenix Limited, Pipeline Products by Development Phase
Agenix Limited, Performance Chart (2009 - 2013)
Agenix Limited, Ratio Charts
Agenix Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Agenix Limited, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: